Delivery Order SPE2DB22D1106-SPE2DB25FDSM4

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,397.92 firm fixed-price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024 and was awarded on November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,177.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of AMNESTEEM 20 MG CAPSULE 30S, a pharmaceutical product, with a performance period running through January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.02 Firm Fixed Price Delivery Order is for the supply of 4566760674 AMNESTEEM 40 MG CAPSULE 30S, with a performance period running through December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,259.68 firm fixed-price delivery order is for the supply of 4566522024 units of the pharmaceutical product AMNESTEEM 20 MG CAPSULE 30S. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,245.81 firm fixed price delivery order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,024.93 Delivery Order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for delivering a range...
This federal contract award is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,457.70 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,148.01 firm-fixed-price delivery order is for the supply of AMNESTEEM 20MG 30S, a prescription medication. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award to Amerisourcebergen Drug Corp for $1,051.26 is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has no set-aside designation and is expected to be completed by August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4565078722 AMNESTEEM 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The $5,292.95 Firm Fixed Price Delivery Order has a completion date of July 8, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDSM4
    Delivery Order

This federal contract award for $9,161.05 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through January 2, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The award was not designated with a set-aside requirement, indicating open competition. No subcontractors were identified in the information provided.

Generated 4/1/25, 10:46 AM